Table 2.
Nitrite | l-Arginine | ADMA | l-Arginine/ADMA | |
Sensitivity | 0.50 (0.31–0.69) | 0.58 (0.39–0.76) | 0.63 (0.42–0.80) | 0.71 (0.51–0.86) |
Specificity | 0.50 (0.46–0.54) | 0.52 (0.48–0.56) | 0.53 (0.48–0.56) | 0.54 (0.50–0.58) |
PPV | 0.18 (0.11–0.25) | 0.20 (0.13–0.27) | 0.22 (0.15–0.28) | 0.25 (0.18–0.30) |
NPV | 0.82 (0.75–0.89) | 0.86 (0.79–0.92) | 0.87 (0.80–0.93) | 0.90 (0.83–0.95) |
Area under ROC curve | 0.48 (0.34–0.62) | 0.52 (0.38–0.65) | 0.63 (0.51–0.75) | 0.63 (0.53–0.73) |
ADMA indicates asymmetric dimethylarginine; NPV, negative predictive value; PPV, positive predictive value. Data are presented as fractions (95% CI). The prevalence of 28-day mortality was 17%. High and low baseline levels were defined by the median.